文献速递帕金森病与运动障碍

基线生活质量可预测早期帕金森病脑深部电刺激的结局

Quality of life predicts outcome of deep brain stimulation in early Parkinson disease.
PubMed 文献 · Neurology · 2019-02-08

该研究对EARLYSTIM试验进行二次分析,比较丘脑底核脑深部电刺激(STN-DBS,n=124)与最佳药物治疗(n=127)2年随访,以PDQ-39-SI为主要终点。结果显示基线PDQ-39-SI与24个月后QOL改善相关(p<0.05),基线评分越高(QOL越差)改善越大,其他基线特征无此相关性。

要点

  • 基线PDQ-39-SI越高(生活质量越差),24个月后生活质量改善越大。
  • 年龄、病程、运动并发症时长及UPDRS评分与QOL改善无显著相关。
  • 选择STN-DBS患者时应系统评估疾病特异性生活质量。

核心结论

  • 患者主观评估的生活质量受损是早期运动并发症帕金森病患者STN-DBS获益的最重要预测因素。

研究设计与样本

  • 对已发表的EARLYSTIM研究进行二次分析,该研究为前瞻性随机试验,比较STN-DBS(n=124)与最佳药物治疗(n=127),随访2年,主要终点为PDQ-39-SI。

主要发现

  • 基线PDQ-39-SI与24个月后PDQ-39-SI变化在两组中均相关(p<0.05)。
  • 基线评分越高(QOL越差),24个月后QOL改善越大。
  • 其他分析的基线特征(年龄、病程、运动并发症时长、UPDRS-III off/on、UPDRS-IV)在两组中均无相关性。

关键数值与推荐

  • 基线PDQ-39-SI与24个月PDQ-39-SI变化相关(p<0.05)。
  • 基线评分越高(QOL越差),24个月后QOL改善越大。

临床怎么用

  • 在选择帕金森病患者进行STN-DBS时,应系统纳入疾病特异性生活质量的评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate predictors for improvement of disease-specific quality of life (QOL) after deep brain stimulation (DBS) of the subthalamic nucleus (STN) for Parkinson disease (PD) with early motor complications. METHODS: We performed a secondary analysis of data from the previously published EARLYSTIM study, a prospective randomized trial comparing STN-DBS (n = 124) to best medical treatment (n = 127) after 2 years follow-up with disease-specific QOL (39-item Parkinson's Disease Questionnaire summary index [PDQ-39-SI]) as the primary endpoint. Linear regression analyses of the baseline characteristics age, disease duration, duration of motor complications, and disease severity measured at baseline with the Unified Parkinson's Disease Rating Scale (UPDRS) (UPDRS-III "off" and "on" medications, UPDRS-IV) were conducted to determine predictors of change in PDQ-39-SI. RESULTS: PDQ-39-SI at baseline was correlated to the change in PDQ-39-SI after 24 months in both treatment groups (p < 0.05). The higher the baseline score (worse QOL) the larger the improvement in QOL after 24 months. No correlation was found for any of the other baseline characteristics analyzed in either treatment group. CONCLUSION: Impaired QOL as subjectively evaluated by the patient is the most important predictor of benefit in patients with PD and early motor complications, fulfilling objective gold standard inclusion criteria for STN-DBS. Our results prompt systematically including evaluation of disease-specific QOL when selecting patients with PD for STN-DBS. CLINICALTRIALSGOV IDENTIFIER: NCT00354133.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Schuepbach WMM, Tonder L, Schnitzler A, et al. Quality of life predicts outcome of deep brain stimulation in early Parkinson disease. Neurology. 2019. PMID: 30737338. doi:10.1212/WNL.0000000000007037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。